Comparison of Two Therapeutic Regimes, Lenalidomide with Dexamethasone and Thalidomide with Dexamethasone, in the Treatment of Multiple Myeloma at a Tertiary Care Hospital in India

Comparison of Two Therapeutic Regimes, Lenalidomide with Dexamethasone and Thalidomide with Dexamethasone, in the Treatment of Multiple Myeloma at a Tertiary Care Hospital in India

Background: Multiple myeloma accounts for 1% of all neoplastic disorders and 10% of all haematological malignancies. Drugs like thalidomide, lenalidomide and bortezomib have emerged as active drugs in the treatment of multiple myeloma.There are few studies which have compared thalidomide-dexamet...

Full description

Bibliographic Details
Main Authors: Nithin Sashidharan, Smita Shenoy, Meena Kumari Kamal Kishore, Harish Thanusubramanian
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2015-05-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
bortezomib
melphalan
neutropenia
thrombocytopenia
Online Access:https://jcdr.net/articles/PDF/5895/11798_CE[Ra_Ash]_F(P)_PF1(PAK)_PFA(AK)_PF2(PAG).pdf

Similar Items

Similar Items